| Similar Articles |
|---|
 |
The Motley Fool
September 1, 2010
Jordan DiPietro |
7 Sinking Health Care Stocks for Savvy Investors Check out these cheap health care stocks: Kendle International... LHC Group... Community Health Services... Almost Family... Universal Health Services... Medical Action Industries... GentivaHealth Services...   |
The Motley Fool
September 1, 2010
Jordan DiPietro |
6 Sinking Chemical Stocks for Savvy Investors Check out these cheap chemical stocks. |
The Motley Fool
September 1, 2010
Jordan DiPietro |
7 Sinking Tech Stocks for Savvy Investors Check out these cheap tech stocks: TeleCommunication Systems... CDC Software... Plexus Corp... Super Micro Computer... Micron Technology... Alpha & Omega Semiconductor... |
The Motley Fool
October 21, 2010
Jordan DiPietro |
3 Sinking Stocks for Savvy Investors These stocks have dropped -- maybe there's an opportunity here? |
The Motley Fool
August 2, 2010
Jordan DiPietro |
3 Sinking Stocks for Savvy Investors Here's a look at large-cap stocks that have fallen the most in a 13-week period. |
The Motley Fool
September 3, 2010
Jordan DiPietro |
7 Big-Time Service Stocks Up for Grabs These large-cap stocks look pretty cheap. |
The Motley Fool
August 17, 2010
Jordan DiPietro |
7 Dirt-Cheap Tech Stocks These highly rated tech stocks are trading at dirt cheap prices. |
The Motley Fool
September 2, 2010
Jordan DiPietro |
6 Big-Time Material Stocks Up for Grabs These large-cap energy stocks look pretty cheap: EnCana... Petrobras... Devon Energy... Occidental Petroleum... Canadian Natural Resources... Statoil SA... |
The Motley Fool
May 24, 2011
Matt Koppenheffer |
Waving the White Flag on Chinese Small Caps Chinese small caps have been blowing up left and right. There may be some attractive looking valuations, but I'm steering clear. |
The Motley Fool
September 2, 2010
Jordan DiPietro |
5 Big-Time Health Service Stocks Up For Grabs These large-cap health-care service stocks look pretty cheap: Stryker... Medtronic... Covidien... WellPoint, Inc... St. Jude Medical... |
The Motley Fool
April 13, 2011
Matt Koppenheffer |
China Small Caps: Whom Can You Trust? Is there any way for investors to venture into the wild world of Chinese small caps? |
The Motley Fool
October 8, 2010
Travis Hoium |
Fuqi International Shares Popped: What You Need to Know I am wary of any company being investigated by the SEC, so watch that you don't get caught in an avalanche if it finds something. |
The Motley Fool
October 21, 2011
Dan Radovsky |
China Questions Big Four Auditors The Chinese government wants the big auditing firms to double-check their work. |
Investment Advisor
October 2005
Ben Warwick |
The Puzzler: Large Cap or Small? We all know that when it comes to stocks, size matters. But bigger isn't always better, especially when the subject under discussion is the equity market. |
The Motley Fool
April 14, 2008
Brian Lawler |
PDL BioPharma's Split Decision PDL BioPharma is finally taking further steps to try to realize better value for the different parts of its business. |
The Motley Fool
April 28, 2011
Brian Orelli |
Buying Royalty Streams on the Cheap If management can't do it, PDL Biopharma's investors are in trouble. The trick is to find patents that are secure and a royalty stream that's predictable. |
The Motley Fool
November 12, 2007
Brian Lawler |
What's New at PDL BioPharma? The past few volatile months are reflected in the third-quarter results from PDL BioPharma. The future, however, may be smoother. Investors, take note. |
The Motley Fool
November 25, 2009
Jennifer Schonberger |
7 Dividend Divas Check out these income stocks for steady dividend returns: Alliance Resource Partners... Altria Group... AT&T... Bristol-Myers Squibb... Southern Company... Eli Lilly... Verizon... |
The Motley Fool
September 24, 2007
Brian Lawler |
Seismic Shifts at PDL No matter what its hedge fund owner, Third Point, decides it wants to do with PDL, one thing is clear: A year from now, PDL BioPharma will not be the same drugmaker that it is today. Investors, take note. |
The Motley Fool
October 31, 2011
Brian D. Pacampara |
4-Star ETFs Poised to Pop: Vanguard Small-Cap Market-trouncing returns could be written in this four-star. |
The Motley Fool
August 18, 2008
Brian Lawler |
When Breaking Up Isn't Hard to Do PDL BioPharma and Enzon are the latest biotechs looking to spin off parts of their business. |
The Motley Fool
September 16, 2008
Selena Maranjian |
Making Money Down the Middle Investing in mid-cap companies can sometimes give you the best of both the large-cap and small-cap worlds. |
The Motley Fool
July 1, 2009
Dan Caplinger |
These Are Stocks You Need to Own Small-caps outdid their large-cap brethren in the second quarter. |
The Motley Fool
May 10, 2011
Dan Caplinger |
7 Small-Cap Values You Need to Watch Small-cap stocks have risen strongly, but some of them still have attractive valuations. |
The Motley Fool
August 14, 2008
Todd Wenning |
Time for a Rebound in China With China shares down big this year, now's the time to consider investing. |
Financial Advisor
September 2009
Raymond Fazzi |
A Small Risk Conventional wisdom says small caps are riskier than their large-cap counterparts, but they remain a basic building block in retirement portfolios. |
The Motley Fool
March 15, 2005
Charly Travers |
PDL Eyeing Up Profits A timely acquisition is paying off for this drug maker. Investors, take note. |
The Motley Fool
December 7, 2011
Dan Caplinger |
Has PDL BioPharma Become the Perfect Stock? Having moved from special dividends to a pure regular-dividend payout has improved income visibility for shareholders. |
The Motley Fool
February 6, 2008
Brian Lawler |
PDL BioPharma Regroups, Piece by Piece The company still brings in plenty of money, despite selling off assets. Investors, take note. |
Financial Advisor
October 2008
Jeff Schlegel |
Small-Cap Surprise This was supposed to be the year of the large-cap stock. A weak U.S. economy in the throes of a wholesale financial quagmire should have spelled trouble for small caps with their mostly domestic focus. Oh well, so much for predictions. |
The Motley Fool
November 16, 2004
Charly Travers |
Finding Biotech's 50-Baggers Finding these superb biotechs isn't a search for a once-in-a-lifetime opportunity. These great investments pop up a lot more frequently than you may think. |
The Motley Fool
January 5, 2012
Sean Williams |
2 Bold Predictions for 2012 Two completely outside-the-box predictions for 2012. |
The Motley Fool
July 9, 2004
Charly Travers |
Protein Design Labs' Windfall Royalties from Genentech could mean big things for PDL. |
The Motley Fool
June 8, 2006
Tim Hanson |
Should You Short Small Caps? After years of reward, so-called contrarians are now turning up their noses at the small-cap fad. |
The Motley Fool
July 14, 2005
Charly Travers |
Dueling Fools: Protein Design Labs Bull Rebuttal This biotech's tomorrow is coming today. The company is a clear buy at its current market cap near $2 billion. |
The Motley Fool
July 6, 2011
Andrew Tonner |
3 Stocks to Save Your Portfolio These sturdy stocks could buoy your portfolio in a dangerous world. |
Financial Advisor
March 2006
Jeff Schlegel |
Waiting For Life In Large Caps History and valuations offer compelling reasons to expect a resurrection in large-cap stocks, say fund managers and financial strategists. |
The Motley Fool
April 7, 2009 |
3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: United States Natural Gas Fund... Arena Pharmaceuticals... |
The Motley Fool
February 19, 2010
Amanda B. Kish |
Are Insiders Buying or Selling? These signs are encouraging for some companies, but not others. |
The Motley Fool
December 18, 2008 |
3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? |
The Motley Fool
March 18, 2009 |
2 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: United States Natural Gas Fund, LP... General Mills, Inc. ... |
The Motley Fool
July 9, 2007
Rich Smith |
Before the Call: Gauging Genentech Investors, don't focus on just this quarter. What's the big picture look like for the drug maker? Many investors seem willing to wait around for this stock. |
The Motley Fool
May 7, 2008
Brian Lawler |
PDL Delivers a Dividend The drugmaker's investors get a hefty payout. |
The Motley Fool
March 30, 2004
Charly Travers |
Genentech: Priced for Perfection Can Genentech's earnings growth keep up with its valuation? The launch of three new products in the last nine months has made Genentech a very popular, and expensive, company. |
The Motley Fool
August 5, 2005
Charly Travers |
No Surprise Over PDL's Upside Protein Design Labs' overwhelmingly positive earnings release is good news for shareholders. |
The Motley Fool
September 26, 2007
Brian Lawler |
Shareholders Pile On Against PDL Another large shareholder has come out against the status quo at PDL BioPharma. Management resignations seen as necessary by those wanting to sell or break apart the biopharma. |
The Motley Fool
March 5, 2008
Brian Lawler |
PDL Taken Off the Block Yesterday, PDL BioPharma announced that it had failed to find an acquirer; instead, it will launch another round of restructuring. |
BusinessWeek
September 3, 2007
Nanette Byrnes |
The Comeback Of Consulting It's once more a huge business for Big Four auditors like Deloitte & Touche, thanks partly to Sarbanes-Oxley rules. |
The Motley Fool
July 16, 2007
Amanda B. Kish |
Large Caps Making a Comeback? So how can smart investors best capitalize on any coming large-cap rebound? Well, don't abandon small caps completely. |
The Motley Fool
August 29, 2007
Brian Lawler |
PDL Lands in a Hazard The biopharma announces a dramatic shift following the failure of its lead drug. Shares of PDL are down only 19% this morning, presumably because the thought of a leaner and thriftier PDL with its royalty-generating potential is a welcome relief to some investors. |
